Search results
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases...
Benzinga via Yahoo Finance· 2 days agoThe terms of the agreement include: A co-exclusive license to co-commercialize Novavax’s current...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 2 days agoNovavax Reports First Quarter 2024 Financial Results and Operational Highlights PR Newswire GAITHERSBURG, Md., May 10, 2024 Announces co-exclusive licensing agreement with ...
Maryland-based Novavax soars on big vaccine deal - WTOP News
WTOP Washington· 2 days agoGaithersburg, Maryland-based Novavax has signed a $1.2 billion licensing agreement with French...
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize...
Benzinga· 3 days agoSanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines ...
Novavax strikes $1.2 billion deal with Sanofi in major turnaround
Axios· 2 days agoDriving the news: Novavax will receive an upfront payment of $500 million and up to $700 million in...
France’s Sanofi in COVID-19 vaccine deal with Novavax
WSAU Wausau· 3 days agoPARIS (Reuters) - Sanofi on Friday announced it has reached a licensing agreement with Novavax to...
Novavax, Sanofi Ink Deal to Commercialize COVID-19 Vaccine to Jointly Produce Combination Shots -...
EconoTimes· 2 days agoNovavax, Inc., a biotechnology company headquartered in Gaithersburg, Maryland, revealed on Friday,...
Novavax's top shareholder Shah Capital ramps up efforts for board shakeup
Reuters· 6 days ago, opens new tab shareholders to vote against the re-election of three directors and proposals...
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine...
WKBN 27 Youngstown· 3 days ago...Agreements and in India, Japan and South Korea where Novavax has existing partnership agreements); a sole license to Novavax's adjuvanted COVID-19 vaccine for use in combination with Sanofi's flu vaccines while Novavax retains the right to and is developing its own COVID-19-Influenza Combination ...
Novavax's Top Shareholder Shah Capital Ramps up Efforts for Board Shakeup
US News & World Report· 6 days agoShah Capital, which currently owns a near 7.5% stake in Novavax and is its third-largest shareholder, reiterated that the company was "undervalued and continues to suffer ...